Elevated succinate, malate (malic acid), and PEP levels were also demonstrated in the CSF of IDH-mutant glioma patients, in our previous study14, suggesting that elevations of these metabolites might be a common finding in the CSF of patients with various types of CNS tumors20. Here, IDH1 is linked to glioma.